Atlas Trials

Affimed GmbH

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Affimed GmbH

RecordFirmDate
Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL (NCT05883449)Affimed GmbH2023-10-10
First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05817058)Affimed GmbH2023-03-21
Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers (NCT05109442)Affimed GmbH2021-11-19
Study to Assess AFM24 in Advanced Solid Cancers (NCT04259450)Affimed GmbH2020-04-07
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides (NCT04101331)Affimed GmbH2019-11-13

Track Affimed GmbH automatically

Every clearance here is in the API, with alerts when new ones post.